EVOTF News and Press, Evotec SE From 04/10/25

HAMBURG, DE / ACCESS Newswire / April 10, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for 2024 on Thursday, 17 April 2025. The Company is going to host a conference call to discuss 2024 results as well as t...

Ongoing strategic partnership advances joint pipeline in neurodegeneration research Evotec receives a $20 million payment to further progress research HAMBURG, DE / ACCESS Newswire / March 4, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN:DE0005664809; NASDAQ:E...

2025-02-18 10:30:00 ET Summary Global stock markets ended 2024 on a down note, with US stocks outperforming due to AI enthusiasm and growth-oriented index heavyweights. The Global Small Companies Equity composite underperformed, mainly due to weak stocks in Industrials and IT sect...

2025-02-18 09:15:00 ET Summary US stocks outperformed international markets in Q4 2024, driven by growth-oriented large-cap stocks and optimism around Trump's business-friendly policies. International small caps fell 7.6% in Q4, largely due to currency weakness, despite a 3.9% gai...

Yonsei University, Zymedi and Evotec receive US$ 4.5m grant from the Korea Institute of Advanced Technology under the Korean Ministry for Trade, Industry and Energy Funding supports a novel collaboration to develop first-in-class therapeutic antibodies to treat asthma and idiopathic pulmon...